ReviewVeterinary sciences2026
Camel-Associated Antimicrobial Resistance: An Overlooked One Health Interface.
Review in Veterinary sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Antimicrobial Use in Dromedary Camels: Off-Label Practices, Welfare Implications, and Antimicrobial Resistance Within a One Health Framework-A Narrative Review.Veterinary sciences · 2026Review
- Camelid VHHs as a Versatile Platform for Combating Viral Infections.Pharmaceuticals (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Camel-associated antimicrobial resistance (AMR) is an underrecognized component of the One Health landscape, particularly in the Gulf Cooperation Council (GCC) and North Africa. Available evidence demonstrates the presence of clinically significant resistance mechanisms in camel populations, including extended-spectrum beta-lactamases, carbapenemases, colistin resistance genes, and multidrug-resistant clones. Molecular similarities between camel and human isolates suggest potential cross-species transmission and highlight camels as possible reservoirs within interconnected human-animal-environment systems. Despite documented resistance patterns, camel production systems remain largely excluded from national AMR surveillance and stewardship frameworks. This gap reflects limited camel-specific data on antimicrobial usage and structural challenges related to pastoral mobility, cross-border trade, and emerging commercial intensification. Strengthening diagnostic capacity, implementing tailored antimicrobial stewardship strategies, and integrating camels into national AMR action plans are essential to mitigate potential public health risks. Proactive inclusion of camel systems within regional AMR governance frameworks is necessary to prevent further amplification of resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.